Literature DB >> 15456108

A cautionary note on the use of the Grønnesby and Borgan goodness-of-fit test for the Cox proportional hazards model.

Susanne May1, David W Hosmer.   

Abstract

Grønnesby and Borgan (1996, Lifetime Data Analysis 2, 315-328) propose an omnibus goodness-of-fit test for the Cox proportional hazards model. The test is based on grouping the subjects by their estimated risk score and comparing the number of observed and a model based estimated number of expected events within each group. We show, using extensive simulations, that even for moderate sample sizes the choice of number of groups is critical for the test to attain the specified size. In light of these results we suggest a grouping strategy under which the test attains the correct size even for small samples. The power of the test statistic seems to be acceptable when compared to other goodness-of-fit tests.

Entities:  

Mesh:

Year:  2004        PMID: 15456108     DOI: 10.1023/b:lida.0000036393.29224.1d

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  4 in total

1.  A global goodness-of-fit statistic for Cox regression models.

Authors:  M Parzen; S R Lipsitz
Journal:  Biometrics       Date:  1999-06       Impact factor: 2.571

2.  A simplified method of calculating an overall goodness-of-fit test for the Cox proportional hazards model.

Authors:  S May; D W Hosmer
Journal:  Lifetime Data Anal       Date:  1998       Impact factor: 1.588

3.  On the bootstrap and monotone likelihood in the cox proportional hazards regression model.

Authors:  T M Loughin
Journal:  Lifetime Data Anal       Date:  1998       Impact factor: 1.588

4.  A method for checking regression models in survival analysis based on the risk score.

Authors:  J K Grønnesby; O Borgan
Journal:  Lifetime Data Anal       Date:  1996       Impact factor: 1.588

  4 in total
  18 in total

1.  Tests of calibration and goodness-of-fit in the survival setting.

Authors:  Olga V Demler; Nina P Paynter; Nancy R Cook
Journal:  Stat Med       Date:  2015-02-11       Impact factor: 2.373

2.  Assessing calibration of prognostic risk scores.

Authors:  Cynthia S Crowson; Elizabeth J Atkinson; Terry M Therneau
Journal:  Stat Methods Med Res       Date:  2013-07-30       Impact factor: 3.021

3.  Prediction of Incident Atrial Fibrillation in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort Study.

Authors:  Leila R Zelnick; Michael G Shlipak; Elsayed Z Soliman; Amanda Anderson; Robert Christenson; James Lash; Rajat Deo; Panduranga Rao; Farsad Afshinnia; Jing Chen; Jiang He; Stephen Seliger; Raymond Townsend; Debbie L Cohen; Alan Go; Nisha Bansal
Journal:  Clin J Am Soc Nephrol       Date:  2021-07-12       Impact factor: 10.614

4.  Performance of the GRACE Risk Score 2.0 Simplified Algorithm for Predicting 1-Year Death After Hospitalization for an Acute Coronary Syndrome in a Contemporary Multiracial Cohort.

Authors:  Wei Huang; Gordon FitzGerald; Robert J Goldberg; Joel Gore; Richard H McManus; Hamza Awad; Molly E Waring; Jeroan Allison; Jane S Saczynski; Catarina I Kiefe; Keith A A Fox; Frederick A Anderson; David D McManus
Journal:  Am J Cardiol       Date:  2016-07-29       Impact factor: 2.778

5.  Fasting plasma glucose and HbA1c in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitus.

Authors:  B Schöttker; H Müller; D Rothenbacher; H Brenner
Journal:  Diabetologia       Date:  2012-09-19       Impact factor: 10.122

6.  Occurrence and predictors of recurrence after a first episode of acute venous thromboembolism: population-based Worcester Venous Thromboembolism Study.

Authors:  Wei Huang; Robert J Goldberg; Frederick A Anderson; Alexander T Cohen; Frederick A Spencer
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

7.  Predictive performances of lipid accumulation product vs. adiposity measures for cardiovascular diseases and all-cause mortality, 8.6-year follow-up: Tehran lipid and glucose study.

Authors:  Mohammadreza Bozorgmanesh; Farzad Hadaegh; Fereidoun Azizi
Journal:  Lipids Health Dis       Date:  2010-09-16       Impact factor: 3.876

8.  Clinical utility of creatinine- and cystatin C-based definition of renal function for risk prediction of primary cardiovascular events in patients with diabetes.

Authors:  Ben Schöttker; Christian Herder; Heiko Müller; Hermann Brenner; Dietrich Rothenbacher
Journal:  Diabetes Care       Date:  2012-02-14       Impact factor: 19.112

9.  Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score.

Authors:  Keith A A Fox; Gordon Fitzgerald; Etienne Puymirat; Wei Huang; Kathryn Carruthers; Tabassome Simon; Pierre Coste; Jacques Monsegu; Philippe Gabriel Steg; Nicolas Danchin; Fred Anderson
Journal:  BMJ Open       Date:  2014-02-21       Impact factor: 2.692

10.  Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW).

Authors:  Gordon FitzGerald; Juliet E Compston; Roland D Chapurlat; Johannes Pfeilschifter; Cyrus Cooper; David W Hosmer; Jonathan D Adachi; Frederick A Anderson; Adolfo Díez-Pérez; Susan L Greenspan; J Coen Netelenbos; Jeri W Nieves; Maurizio Rossini; Nelson B Watts; Frederick H Hooven; Andrea Z LaCroix; Lyn March; Christian Roux; Kenneth G Saag; Ethel S Siris; Stuart Silverman; Stephen H Gehlbach
Journal:  J Clin Endocrinol Metab       Date:  2014-01-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.